Human autologous synovial stem cells therapy（FUJIFILM Toyama）

N/A

Report date: 2023/03/23 20:01:40

Base Information

Drug NameHuman autologous synovial stem cells therapy（FUJIFILM Toyama）

Drug Alias NameFF-31501

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Synovium-derived

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsMeniscus Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesFujifilm Toyama Chemical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesFujifilm Toyama Chemical Co Ltd

Inactive CompaniesN/A

Active IndicationsMeniscus Injuries

Inactive IndicationsN/A

Other Information

ATC CodeN/A